|
NBEAL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.32949999956489E-07 |
| Normal-vs-Stage3 |
1.63939999997531E-06 |
| Normal-vs-Stage4 |
1.97920000000185E-06 |
| Stage1-vs-Stage2 |
1.475200E-01 |
| Stage1-vs-Stage3 |
1.312650E-01 |
| Stage1-vs-Stage4 |
7.428000E-01 |
| Stage2-vs-Stage3 |
8.458000E-01 |
| Stage2-vs-Stage4 |
5.367800E-01 |
| Stage3-vs-Stage4 |
5.016800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
7.15989489918911E-11 |
| Normal-vs-Asian |
3.610900E-04 |
| Caucasian-vs-AfricanAmerican |
3.343400E-01 |
| Caucasian-vs-Asian |
7.450800E-01 |
| AfricanAmerican-vs-Asian |
9.835000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.20029999945071E-07 |
| Male-vs-Female |
2.2446999999981E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.21610002255113E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.73070446862766E-11 |
| Normal-vs-Extreme_Obese |
1.51226999999254E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.348200E-02 |
| Normal_Weight-vs-Obese |
5.719600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.320400E-01 |
| Extreme_Weight-vs-Obese |
1.697270E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.566100E-02 |
| Obese-vs-Extreme_Obese |
9.726200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.66120000000469E-05 |
| Normal-vs-Age(41-60Yrs) |
5.1370019349406E-13 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
5.64050000040339E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.015600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.402400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.982000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.299900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.677600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.885600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.41869968498065E-10 |
| Normal-VS-KIRP CIMP |
1.500070E-03 |
| Normal-VS-Unclassified PRCC |
1.04499999997731E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.839700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.666600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.904400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.155800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.941400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.908600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-16 |
| Normal-vs-N1 |
1.91520999999195E-05 |
| Normal-vs-N2 |
1.395760E-03 |
| N0-vs-N1 |
8.635600E-02 |
| N0-vs-N2 |
6.406600E-01 |
| N1-vs-N2 |
6.484000E-01 |
|
|
